Showing 1 - 4 results of 4 for search '"glecaprevir/pibrentasvir"', query time: 0.03s Refine Results
  1. 1
    Effectiveness of Glecaprevir/Pibrentasvir in Patients with Chronic HCV-infection Genotypes 1 to 6 in the real-world settings in Russia (EVEREST study)

    Effectiveness of Glecaprevir/Pibrentasvir in Patients with Chronic HCV-infection Genotypes 1 to 6 in the real-world settings in Russia (EVEREST study) by О. I. Sagalova, V. S. Adonieva, S. V. Zotov, D. A. Gusev, E. A. Strebkova, R. B. Galbraikh, V. G. Morozov, I. M. Khayertynova, I. V. Krasilnikova, I. V. Sannikova, A. Bhagat, D. O. Milenin, A. P. Efremova

    Published 2023-07-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg

    Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg by D. A. Gusev, K. V. Zhdanov, K. V. Kozlov, T. N. Vinogradova, M. Yu. Kopot, V. S. Sukachev, S. S. Zhabrov, S. N. Kizhlo, S. Yu. Romanova, V. B. Musatov, N. V. Tyurenkova, Yu. A. Vlasova, E. Yu. Kolpashchikova, P. N. Fedorov, P. V. Minin, T. S. Korneeva

    Published 2023-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

    Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide by Aleksandra Berkan-Kawińska, Anna Piekarska, Hanna Berak, Włodzimierz Mazur, Aleksander Garlicki, Magdalena Tudrujek-Zdunek, Beata Lorenc, Dorota Dybowska, Łukasz Socha, Anna Parfieniuk-Kowerda, Robert Flisiak

    Published 2024-07-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan

    Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administ... by Daisuke Nakamoto, Yi Piao, Hajime Mizutani, Ryozo Wakabayashi, Satoshi Otokita, Alice Stead, Candido Hernandez, Masahisa Jinushi

    Published 2025-04-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: